Molecular role of RNF43 in canonical and noncanonical Wnt signaling

Molecular and Cellular Biology

Volumn 35, Issue 11, 2015, Pages 2007-2023

  Tsukiyama, Tadasuke ^a   Fukui, Akimasa ^b   Terai, Sayuri ^a   Fujioka, Yoichiro ^a   Shinada, Keisuke ^a   Takahashi, Hidehisa ^a   Yamaguchi, Terry P ^c   Ohba, Yusuke ^a   Hatakeyama, Shigetsugu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DISHEVELLED 2; DISHEVELLED PROTEIN; FRIZZLED PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE RNF43; UNCLASSIFIED DRUG; WNT3A PROTEIN; WNT5A PROTEIN; WNT8A PROTEIN; CYTOSKELETON PROTEIN; DNA BINDING PROTEIN; ONCOPROTEIN; RNF43 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; WNT PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EMBRYO; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL SURFACE; CELLULAR DISTRIBUTION; COLORECTAL CANCER; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDOPLASMIC RETICULUM; ENDOSOME; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEK293 CELL LINE; HELA CELL LINE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MISSENSE MUTATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS TUMOR; PDZ DOMAIN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RING FINGER MOTIF; WNT SIGNALING PATHWAY; XENOPUS; CELL LINE; CYTOPLASM; GENETICS; HCT116 CELL LINE; HEPG2 CELL LINE; MCF 7 CELL LINE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BETA CATENIN; CELL LINE; CELL LINE, TUMOR; CYTOPLASM; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; ENDOPLASMIC RETICULUM; ENDOSOMES; FRIZZLED RECEPTORS; HCT116 CELLS; HEK293 CELLS; HELA CELLS; HEP G2 CELLS; HUMANS; MCF-7 CELLS; MUTATION, MISSENSE; ONCOGENE PROTEINS; RING FINGER DOMAINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84929439294     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00159-15     Document Type: Article

References (49)

1. Yamaguchi TP. 2001. Heads or tails: Wnts and anterior-posterior patterning. Curr Biol 11:R713-R724. http://dx.doi.org/10.1016/S0960-9822(01)00417-1.
2. Logan CY, Nusse R. 2004. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781-810. http://dx.doi.org/10.1146/annurev.cellbio.20.010403.113126.
3. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. 2004. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5:691-701. http://dx.doi.org/10.1038/nrg1427.
4. MacDonald BT, Tamai K, He X. 2009. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17:9-26. http://dx.doi.org/10.1016/j.devcel.2009.06.016.
5. Kikuchi A, Yamamoto H, Sato A, Matsumoto S. 2012. Wnt5a: its signalling, functions and implication in diseases. Acta Physiol 204:17-33. http://dx.doi.org/10.1111/j.1748-1716.2011.02294.x.
6. Clevers H, Nusse R. 2012. Wnt/beta-catenin signaling and disease. Cell 149:1192-1205. http://dx.doi.org/10.1016/j.cell.2012.05.012.
7. Kikuchi A, Yamamoto H, Sato A. 2009. Selective activation mechanisms of Wnt signaling pathways. Trends Cell Biol 19:119-129. http://dx.doi.org/10.1016/j.tcb.2009.01.003.
8. Torres MA, Yang-Snyder JA, Purcell SM, DeMarais AA, McGrew LL, Moon RT. 1996. Activities of the Wnt-1 class of secreted signaling factors are antagonized by the Wnt-5A class and by a dominant negative cadherin in early Xenopus development. J Cell Biol 133:1123-1137. http://dx.doi.org/10.1083/jcb.133.5.1123.
9. Kitagawa M, Hatakeyama S, Shirane M, Matsumoto M, Ishida N, Hattori K, Nakamichi I, Kikuchi A, Nakayama K. 1999. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of betacatenin. EMBO J 18:2401-2410. http://dx.doi.org/10.1093/emboj/18.9.2401.
10. Roose J, Molenaar M, Peterson J, Hurenkamp J, Brantjes H, Moerer P, van de Wetering M, Destree O, Clevers H. 1998. The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature 395:608-612. http://dx.doi.org/10.1038/26989.
11. Yamaguchi TP, Bradley A, McMahon AP, Jones S. 1999. A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 126:1211-1223.
12. Mikels AJ, Nusse R. 2006. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 4:e115. http://dx.doi.org/10.1371/journal.pbio.0040115.
13. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL, White RL, Matsunami N. 2001. Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 7:927-936. http://dx.doi.org/10.1016/S1097-2765(01)00241-6.
14. Matsuzawa SI, Reed JC. 2001. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 7:915-926. http://dx.doi.org/10.1016/S1097-2765(01)00242-8.
15. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. 2003. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162:899-908. http://dx.doi.org/10.1083/jcb.200303158.
16. Ishitani T, Ninomiya-Tsuji J, Nagai S, Nishita M, Meneghini M, Barker N, Waterman M, Bowerman B, Clevers H, Shibuya H, Matsumoto K. 1999. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature 399:798-802. http://dx.doi.org/10.1038/21674.
17. Ishitani T, Kishida S, Hyodo-Miura J, Ueno N, Yasuda J, Waterman M, Shibuya H, Moon RT, Ninomiya-Tsuji J, Matsumoto K. 2003. The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol Cell Biol 23:131-139. http://dx.doi.org/10.1128/MCB.23.1.131-139.2003.
18. Polakis P. 2007. The many ways of Wnt in cancer. Curr Opin Genet Dev 17:45-51. http://dx.doi.org/10.1016/j.gde.2006.12.007.
19. Tauriello DV, Maurice MM. 2010. The various roles of ubiquitin in Wnt pathway regulation. Cell Cycle 9:3700-3709. http://dx.doi.org/10.4161/cc.9.18.13204.
20. Mukai A, Yamamoto-Hino M, Awano W, Watanabe W, Komada M, Goto S. 2010. Balanced ubiquitylation and deubiquitylation of Frizzled regulate cellular responsiveness to Wg/Wnt. EMBO J 29:2114-2125. http://dx.doi.org/10.1038/emboj.2010.100.
21. Miyazaki K, Fujita T, Ozaki T, Kato C, Kurose Y, Sakamoto M, Kato S, Goto T, Itoyama Y, Aoki M, Nakagawara A. 2004. NEDL1, a novel ubiquitin-protein isopeptide ligase for dishevelled-1, targets mutant superoxide dismutase-1. J Biol Chem 279:11327-11335. http://dx.doi.org/10.1074/jbc.M312389200.
22. Simons M, Gloy J, Ganner A, Bullerkotte A, Bashkurov M, Kronig C, Schermer B, Benzing T, Cabello OA, Jenny A, Mlodzik M, Polok B, Driever W, Obara T, Walz G. 2005. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat Genet 37:537-543. http://dx.doi.org/10.1038/ng1552.
23. Tauriello DV, Haegebarth A, Kuper I, Edelmann MJ, Henraat M, Canninga-van Dijk MR, Kessler BM, Clevers H, Maurice MM. 2010. Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl. Mol Cell 37:607-619. http://dx.doi.org/10.1016/j.molcel.2010.01.035.
24. Zhang Y, Liu S, Mickanin C, Feng Y, Charlat O, Michaud GA, Schirle M, Shi X, Hild M, Bauer A, Myer VE, Finan PM, Porter JA, Huang SM, Cong F. 2011. RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling. Nat Cell Biol 13:623-629. http://dx.doi.org/10.1038/ncb2222.
25. Callow MG, Tran H, Phu L, Lau T, Lee J, Sandoval WN, Liu PS, Bheddah S, Tao J, Lill JR, Hongo JA, Davis D, Kirkpatrick DS, Polakis P, Costa M. 2011. Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling. PLoS One 6:e22595. http://dx.doi.org/10.1371/journal.pone.0022595.
26. Choi J, Park SY, Costantini F, Jho EH, Joo CK. 2004. Adenomatous polyposis coli is down-regulated by the ubiquitin-proteasome pathway in a process facilitated by Axin. J Biol Chem 279:49188-49198. http://dx.doi.org/10.1074/jbc.M404655200.
27. Hao HX, Xie Y, Zhang Y, Charlat O, Oster E, Avello M, Lei H, Mickanin C, Liu D, Ruffner H, Mao X, Ma Q, Zamponi R, Bouwmeester T, Finan PM, Kirschner MW, Porter JA, Serluca FC, Cong F. 2012. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485:195-200. http://dx.doi.org/10.1038/nature11019.
28. Koo BK, Spit M, Jordens I, Low TY, Stange DE, van de Wetering M, van Es JH, Mohammed S, Heck AJ, Maurice MM, Clevers H. 2012. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488:665-669. http://dx.doi.org/10.1038/nature11308.
29. Shinada K, Tsukiyama T, Sho T, Okumura F, Asaka M, Hatakeyama S. 2011. RNF43 interacts with NEDL1 and regulates p53-mediated transcription. Biochem Biophys Res Commun 404:143-147. http://dx.doi.org/10.1016/j.bbrc.2010.11.082.
30. Morita S, Kojima T, Kitamura T. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7:1063-1066. http://dx.doi.org/10.1038/sj.gt.3301206.
31. Jiang X, Hao HX, Growney JD, Woolfenden S, Bottiglio C, Ng N, Lu B, Hsieh MH, Bagdasarian L, Meyer R, Smith TR, Avello M, Charlat O, Xie Y, Porter JA, Pan S, Liu J, McLaughlin ME, Cong F. 2013. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A 110:12649-12654. http://dx.doi.org/10.1073/pnas.1307218110.
32. Matsuda M, Tsukiyama T, Bohgaki M, Nonomura K, Hatakeyama S. 2007. Establishment of a newly improved detection system for NF-kappaB activity. Immunol Lett 109:175-181. http://dx.doi.org/10.1016/j.imlet.2007.02.007.
33. Wu J, Jiao Y, Dal Molin M, Maitra A, de Wilde RF, Wood LD, Eshleman JR, Goggins MG, Wolfgang CL, Canto MI, Schulick RD, Edil BH, Choti MA, Adsay V, Klimstra DS, Offerhaus GJ, Klein AP, Kopelovich L, Carter H, Karchin R, Allen PJ, Schmidt CM, Naito Y, Diaz LA, Jr, Kinzler KW, Papadopoulos N, Hruban RH, Vogelstein B. 2011. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A 108:21188-21193. http://dx.doi.org/10.1073/pnas.1118046108.
34. Ong CK, Subimerb C, Pairojkul C, Wongkham S, Cutcutache I, Yu W, McPherson JR, Allen GE, Ng CC, Wong BH, Myint SS, Rajasegaran V, Heng HL, Gan A, Zang ZJ, Wu Y, Wu J, Lee MH, Huang D, Ong P, Chan-on W, Cao Y, Qian CN, Lim KH, Ooi A, Dykema K, Furge K, Kukongviriyapan V, Sripa B, Wongkham C, Yongvanit P, Futreal PA, Bhudhisawasdi V, Rozen S, Tan P, Teh BT. 2012. Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat Genet 44:690-693. http://dx.doi.org/10.1038/ng.2273.
35. Chen PH, Chen X, Lin Z, Fang D, He X. 2013. The structural basis of R-spondin recognition by LGR5 and RNF43. Genes Dev 27:1345-1350. http://dx.doi.org/10.1101/gad.219915.113.
36. He X, Saint-Jeannet JP, Wang Y, Nathans J, Dawid I, Varmus H. 1997. A member of the Frizzled protein family mediating axis induction by Wnt-5A. Science 275:1652-1654. http://dx.doi.org/10.1126/science.275.5306.1652.
37. van Amerongen R, Fuerer C, Mizutani M, Nusse R. 2012. Wnt5a can both activate and repress Wnt/beta-catenin signaling during mouse embryonic development. Dev Biol 369:101-114. http://dx.doi.org/10.1016/j.ydbio.2012.06.020.
38. Grossmann AH, Yoo JH, Clancy J, Sorensen LK, Sedgwick A, Tong Z, Ostanin K, Rogers A, Grossmann KF, Tripp SR, Thomas KR, D'Souza-Schorey C, Odelberg SJ, Li DY. 2013. The small GTPase ARF6 stimulates beta-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis. Sci Signal 6:ra14. http://dx.doi.org/10.1126/scisignal.2003398.
39. de Lau W, Peng WC, Gros P, Clevers H. 2014. The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength. Genes Dev 28:305-316. http://dx.doi.org/10.1101/gad.235473.113.
40. Glinka A, Dolde C, Kirsch N, Huang YL, Kazanskaya O, Ingelfinger D, Boutros M, Cruciat CM, Niehrs C. 2011. LGR4 and LGR5 are R-spondin receptors mediating Wnt/-catenin and Wnt/PCP signalling. EMBO Rep 12:1055-1061. http://dx.doi.org/10.1038/embor.2011.175.
41. Lee HJ, Zheng JJ. 2010. PDZ domains and their binding partners: structure, specificity, and modification. Cell Commun Signal 8:8. http://dx.doi.org/10.1186/1478-811X-8-8.
42. Wong HC, Bourdelas A, Krauss A, Lee HJ, Shao Y, Wu D, Mlodzik M, Shi DL, Zheng J. 2003. Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled. Mol Cell 12:1251-1260. http://dx.doi.org/10.1016/S1097-2765(03)00427-1.
43. Punchihewa C, Ferreira AM, Cassell R, Rodrigues P, Fujii N. 2009. Sequence requirement and subtype specificity in the high-affinity interaction between human frizzled and dishevelled proteins. Protein Sci 18:994-1002. http://dx.doi.org/10.1002/pro.109.
44. Yagyu R, Furukawa Y, Lin YM, Shimokawa T, Yamamura T, Nakamura Y. 2004. A novel oncoprotein RNF43 functions in an autocrine manner in colorectal cancer. Int J Oncol 25:1343-1348.
45. Obata Y, Toyoshima S, Wakamatsu E, Suzuki S, Ogawa S, Esumi H, Abe R. 2014. Oncogenic kit signals on endolysosomes and endoplasmic reticulum are essential for neoplastic mast cell proliferation. Nat Commun 5:5715. http://dx.doi.org/10.1038/ncomms6715.
46. Holland JD, Klaus A, Garratt AN, Birchmeier W. 2013. Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol 25:254-264. http://dx.doi.org/10.1016/j.ceb.2013.01.004.
47. Sugimura R, He XC, Venkatraman A, Arai F, Box A, Semerad C, Haug JS, Peng L, Zhong XB, Suda T, Li L. 2012. Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche. Cell 150:351-365. http://dx.doi.org/10.1016/j.cell.2012.05.041.
48. Ryland GL, Hunter SM, Doyle MA, Rowley SM, Christie M, Allan PE, Bowtell DD, Gorringe KL, Campbell IG. 2013. RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary. J Pathol 229:469-476. http://dx.doi.org/10.1002/path.4134.
49. Xing C, Zhou W, Ding S, Xie H, Zhang W, Yang Z, Wei B, Chen K, Su R, Cheng J, Zheng S, Zhou L. 2013. Reversing effect of ring finger protein 43 inhibition on malignant phenotypes of human hepatocellular carcinoma. Mol Cancer Ther 12:94-103. http://dx.doi.org/10.1158/1535-7163.MCT-12-0672.